Ellen van der Plas1, Laurie Gutmann2,3, Dan Thedens4, Richard K Shields5, Kathleen Langbehn1, Zhihui Guo6, Milan Sonka6, Peggy Nopoulos1. 1. Department of Psychiatry, University of Iowa Hospital & Clinics, Iowa City, Iowa, USA. 2. Department of Neurology, University of Iowa Hospital & Clinics, Iowa City, Iowa, USA. 3. Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA. 4. Department of Radiology, University of Iowa Hospital & Clinics, Iowa City, Iowa, USA. 5. Department of Physical Therapy and Rehabilitation Science, University of Iowa Hospital & Clinics, Iowa City, Iowa, USA. 6. Iowa Institute for Biomedical Imaging, University of Iowa, Iowa City, Iowa, USA.
Abstract
BACKGROUND: Quantitative muscle MRI as a sensitive marker of early muscle pathology and disease progression in adult-onset myotonic dystrophy type 1. The utility of muscle MRI as a marker of muscle pathology and disease progression in adult-onset myotonic dystrophy type 1 (DM1) was evaluated. METHODS: This prospective, longitudinal study included 67 observations from 36 DM1 patients (50% female), and 92 observations from 49 healthy adults (49% female). Lower-leg 3T magnetic resonance imaging (MRI) scans were acquired. Volume and fat fraction (FF) were estimated using a three-point Dixon method, and T2-relaxometry was determined using a multi-echo spin-echo sequence. Muscles were segmented automatically. Mixed linear models were conducted to determine group differences across muscles and image modality, accounting for age, sex, and repeated observations. Differences in rate of change in volume, T2-relaxometry, and FF were also determined with mixed linear regression that included a group by elapsed time interaction. RESULTS: Compared with healthy adults, DM1 patients exhibited reduced volume of the tibialis anterior, soleus, and gastrocnemius (GAS) (all, P < .05). T2-relaxometry and FF were increased across all calf muscles in DM1 compared to controls. (all, P < .01). Signs of muscle pathology, including reduced volume, and increased T2-relaxometry and FF were already noted in DM1 patients who did not exhibit clinical motor symptoms of DM1. As a group, DM1 patients exhibited a more rapid change than did controls in tibialis posterior volume (P = .05) and GAS T2-relaxometry (P = .03) and FF (P = .06). CONCLUSIONS: Muscle MRI renders sensitive, early markers of muscle pathology and disease progression in DM1. T2 relaxometry may be particularly sensitive to early muscle changes related to DM1.
BACKGROUND: Quantitative muscle MRI as a sensitive marker of early muscle pathology and disease progression in adult-onset myotonic dystrophy type 1. The utility of muscle MRI as a marker of muscle pathology and disease progression in adult-onset myotonic dystrophy type 1 (DM1) was evaluated. METHODS: This prospective, longitudinal study included 67 observations from 36 DM1 patients (50% female), and 92 observations from 49 healthy adults (49% female). Lower-leg 3T magnetic resonance imaging (MRI) scans were acquired. Volume and fat fraction (FF) were estimated using a three-point Dixon method, and T2-relaxometry was determined using a multi-echo spin-echo sequence. Muscles were segmented automatically. Mixed linear models were conducted to determine group differences across muscles and image modality, accounting for age, sex, and repeated observations. Differences in rate of change in volume, T2-relaxometry, and FF were also determined with mixed linear regression that included a group by elapsed time interaction. RESULTS: Compared with healthy adults, DM1 patients exhibited reduced volume of the tibialis anterior, soleus, and gastrocnemius (GAS) (all, P < .05). T2-relaxometry and FF were increased across all calf muscles in DM1 compared to controls. (all, P < .01). Signs of muscle pathology, including reduced volume, and increased T2-relaxometry and FF were already noted in DM1 patients who did not exhibit clinical motor symptoms of DM1. As a group, DM1 patients exhibited a more rapid change than did controls in tibialis posterior volume (P = .05) and GAS T2-relaxometry (P = .03) and FF (P = .06). CONCLUSIONS: Muscle MRI renders sensitive, early markers of muscle pathology and disease progression in DM1. T2 relaxometry may be particularly sensitive to early muscle changes related to DM1.
Authors: Masayuki Nakamori; Krzysztof Sobczak; Araya Puwanant; Steve Welle; Katy Eichinger; Shree Pandya; Jeannne Dekdebrun; Chad R Heatwole; Michael P McDermott; Tian Chen; Melissa Cline; Rabi Tawil; Robert J Osborne; Thurman M Wheeler; Maurice S Swanson; Richard T Moxley; Charles A Thornton Journal: Ann Neurol Date: 2013-12 Impact factor: 10.422
Authors: Richard T Moxley; Eric L Logigian; William B Martens; Chris L Annis; Shree Pandya; Richard T Moxley; Cheryl A Barbieri; Nuran Dilek; Allen W Wiegner; Charles A Thornton Journal: Muscle Nerve Date: 2007-09 Impact factor: 3.217
Authors: Linda Heskamp; Marlies van Nimwegen; Marieke J Ploegmakers; Guillaume Bassez; Jean-Francois Deux; Sarah A Cumming; Darren G Monckton; Baziel G M van Engelen; Arend Heerschap Journal: Neurology Date: 2019-05-22 Impact factor: 9.910
Authors: Ellen van der Plas; Mark J Hamilton; Jacob N Miller; Timothy R Koscik; Jeffrey D Long; Sarah Cumming; Julija Povilaikaite; Maria Elena Farrugia; John McLean; Ravi Jampana; Vincent A Magnotta; Laurie Gutmann; Darren G Monckton; Peggy C Nopoulos Journal: J Neuromuscul Dis Date: 2019